Doximity, Inc. (DOCS)
USD 58.04
(2.04%)
USD 58.04
(2.04%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -82.23 Million USD | 42.24% |
| 2023 | -142.39 Million USD | -27.45% |
| 2022 | -111.72 Million USD | -71.51% |
| 2021 | -65.13 Million USD | -41.16% |
| 2020 | -46.14 Million USD | -37.31% |
| 2019 | -33.6 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | -82.23 Million USD | 42.24% |
| 2024 Q1 | -291.09 Million USD | -104.44% |
| 2024 Q3 | -108.03 Million USD | -15.73% |
| 2024 Q2 | -93.34 Million USD | 67.93% |
| 2024 Q4 | -82.23 Million USD | 23.88% |
| 2023 Q1 | -98.32 Million USD | 11.99% |
| 2023 FY | -142.39 Million USD | -27.45% |
| 2023 Q4 | -142.39 Million USD | -17.86% |
| 2023 Q3 | -120.81 Million USD | -108.17% |
| 2023 Q2 | -58.03 Million USD | 40.97% |
| 2022 Q1 | -593.53 Million USD | -811.19% |
| 2022 FY | -111.72 Million USD | -71.51% |
| 2022 Q4 | -111.72 Million USD | -33.82% |
| 2022 Q3 | -83.48 Million USD | -5.8% |
| 2022 Q2 | -78.9 Million USD | 86.71% |
| 2021 Q1 | 86.44 Million USD | 279.7% |
| 2021 Q3 | -69.55 Million USD | 0.0% |
| 2021 Q4 | -65.13 Million USD | 6.35% |
| 2021 FY | -65.13 Million USD | -41.16% |
| 2020 Q4 | -48.1 Million USD | 0.0% |
| 2020 FY | -46.14 Million USD | -37.31% |
| 2019 FY | -33.6 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Well Corporation | -360.25 Million USD | 77.172% |
| Evolent Health, Inc. | 451.97 Million USD | 118.196% |
| MultiPlan Corporation | 4.48 Billion USD | 101.833% |
| Phreesia, Inc. | -75.53 Million USD | -8.872% |
| Teladoc Health, Inc. | 468.6 Million USD | 117.55% |
| Veeva Systems Inc. | -647.71 Million USD | 87.303% |